← FDA Drug Approvals (Drugs@FDA)
DANOCRINE
NDA · New Drug Application · Sponsor: SANOFI AVENTIS US · Approved 1976-06-21
Drug application
- FDA Application #
NDA017557- Application type
- New Drug Application
- Brand name
- DANOCRINE
- Generic name
- Danazol
- Active ingredients
- DANAZOL
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- SANOFI AVENTIS US
- First approval
- 1976-06-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown